Checkpoint Therapeutics Inc CKPT
$4.26 $0.03 (0.71%) 1D
Last Updated: May 29, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Checkpoint Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of CKPT Stock
Germany Health Care Small Cap No. As of September 2026, Checkpoint Therapeutics Inc (CKPT) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Checkpoint Therapeutics Inc does not pass Musaffa's business and financial screening criteria.
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company is headquartered in Waltham, Massachusetts and currently employs 24 full-time employees. The company went IPO on 2016-11-02. The firm is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-programmed death-ligand 1 (PD-L1) antibody licensed from the Dana-Farber Cancer Institute, as a potential new treatment for patients with selected recurrent or metastatic cancers, including metastatic and locally advanced cutaneous squamous cell carcinoma. The firm is also evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer. Its anti-GITR monoclonal antibody, CK-302, is a fully human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells.
CKPT Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Checkpoint Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Checkpoint Therapeutics Inc (CKPT) Chart
Financial Metrics & Statements of Checkpoint Therapeutics Inc (CKPT)
FAQ's for Checkpoint Therapeutics Inc (CKPT)
- As of September 2026, Checkpoint Therapeutics Inc CKPT is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Checkpoint Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Checkpoint Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Checkpoint Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Checkpoint Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Checkpoint Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Checkpoint Therapeutics Inc (CKPT)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
